Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8651750 | The American Journal of the Medical Sciences | 2018 | 16 Pages |
Abstract
Our results indicate high-dose irbesartan combined with spironolactone may be more efficient in reducing UAER in elderly patients with early DN, but this treatment could cause hyperkalemia. Low-dose irbesartan combined with spironolactone was shown to be safer and more effective in decreasing UAER compared to high-dose irbesartan.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Yingying MS, Peng PhD, Xia MS, Yanan MS, Fengmei MS, Yangang PhD,